CORTERIX
Corterix is the beautifully unified platform that ingests structured and unstructured data in real time, indexes and compresses it, and loads it into a single SQL database. CORTERIX enables the ingestion, transformation, indexing and loading of unstructured and structured data over up to 4 million channels into a single SQL database. All data loaded into the database can be queried using SQL, R and via industry standard interfaces immediately after data is committed by the SQL database. Since CORTERIX enables a true data lake, all queries execute against all loaded data. No intermediate tables are required. No programming or integration is required. CORTERIX can also address embedded analytic use cases, such as intelligent archival.
CORTERIX
Social Links:
Industry:
Analytics Information Technology Robotics Software
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.corterix.com
Status:
Active
Contact:
1(650)209-6507
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt WordPress Content Delivery Network Font Awesome Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
Satori
Satori is the R&D platform for indoor & greenhouse agriculture, a next-generation environmental monitoring and optimization solution.
Newest Events participated
Participated in Collision 2017
on 2017-05-02 as exhibitor
Official Site Inspections
http://www.corterix.com
- Host name: 192-254-234-221.unifiedlayer.com
- IP address: 192.254.234.221
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Corterix"
Home page - Corteria
About us FOCUSED ON THE DEVELOPMENT OF TRANSFORMATIVE THERAPIES FOR THE TREATMENT OF WORSENING AND ACUTE DECOMPENSATED HEART FAILURE …See details»
Corterix - Crunchbase Company Profile & Funding
Organization. Corterix . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Corterix is the unified platform that ingests structured and …See details»
Corterix Company Profile | Management and Employees List
Company Name. Corterix. Main Industry. Custom Software & IT Services, Business Services. Website. www.corterix.comSee details»
Corteria Pharmaceuticals - Crunchbase Company Profile & Funding
Corteria Pharmaceuticals closed its last funding round on Sep 7, 2023 from a Series A round. Who are Corteria Pharmaceuticals 's competitors? Alternatives and possible competitors to …See details»
Corteria Pharmaceuticals - PitchBook
Is Corteria Pharmaceuticals a private or public company? Corteria Pharmaceuticals is a Private company. What is Corteria Pharmaceuticals’s current revenue? The current revenue for …See details»
Corterix - Company Profile - Tracxn
Oct 23, 2024 Corterix ranks 951st among 951 competitors. 150 of its competitors are funded while 52 have exited. Overall, Corterix and its competitors have raised over $8.15B in funding …See details»
Corteria Pharmaceuticals SAS - Drug pipelines, Patents ... - Patsnap
Corteria’s innovative approach is centered on selecting therapeutic targets involved in the worsening and acute forms of human heart failure, as well as a stratification strategy to identify …See details»
Corteria Pharmaceuticals - Funding, Financials, Valuation & Investors
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... How …See details»
Corteria Pharmaceuticals Announces a €65M ($71M) Financing to …
Paris (France), 07 September 2023 – Corteria Pharmaceuticals (“Corteria”), a biopharmaceutical company specialized in the development of transformative therapies for unaddressed heart …See details»
Corteria Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The …
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute …See details»
Corteria Pharmaceuticals - Company Profile - Tracxn
Nov 27, 2024 Corteria Pharmaceuticals. has raised a total funding of $83.3M over 2 rounds. Its first funding round was on Dec 09, 2021. What are the most recent funding rounds of Corteria …See details»
Corteria Pharmaceuticals - VentureRadar
Founded in 2021, Corteria Pharmaceuticals is a privately held company developing first-in-class drugs in heart failure subpopulations. Our strategy implies innovative patient stratification and …See details»
Leadership - Corteria
Regis brings more than 30 years of experience in the areas of finance, structuring and management of health technology companies. Prior to joining Corteria, Regis was CEO of …See details»
Corteria Pharmaceuticals Announces a €65M Financing to Advance ...
Sep 7, 2023 Corteria Pharmaceuticals (“Corteria”), a biopharmaceutical company specialized in the development of transformative therapies for unaddressed heart failure subpopulations, …See details»
Corteria Pharmaceuticals - EU-Startups
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute …See details»
Corteria Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Corteria Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. ... Corteria Pharmaceuticals has 3 current employee profiles, including Founder & …See details»
Corteria Pharmaceuticals announces initiation of Phase 1 study to ...
Mar 26, 2024 Corteria Pharmaceuticals (‘Corteria’), a clinical-stage biopharmaceutical company focused on the development of transformative therapies for heart failure and obesity, today …See details»
Corteria: a new strategy and approach to treating heart failure
Apr 25, 2023 Corteria Pharmaceuticals is developing transformative therapies for heart failure subpopulations most likely to benefit from the company’s novel cardiorenal treatments. The …See details»
French biotech Corteria secures $70M to revive ex-Sanofi heart …
Sep 7, 2023 Philip Janiak, Corteria Pharmaceuticals CEO. September 7, 2023 03:00 AM EDT. Financing. French biotech Corteria secures $70M to revive ex-Sanofi heart drugs ...See details»
Abstract 4138674: Long-acting CRF2 receptor agonist, COR-1389, …
Nov 11, 2024 Corteria Pharmaceuticals, Paris, France. View all articles by this author. Francesca Lawson, MD. Corteria Pharmaceuticals, Paris, France. ... The American Heart …See details»